| Date | Presentation | Download |
|---|---|---|
| 14/12 |
Update on EU-Funded Nipah Virus Vaccine Project |
 |
| 23/11 |
Finwire interview with CEO Bent Frandsen, 23 November 2023 |
|
| 22/11 |
Presentation at Økonomisk Ugebrev Life Science Investor Conference |
|
| 16/11 |
Presentation of third quarter 2023 results |
|
| 31/8 |
H.C. Andersen Capital Life Science Seminar Presentation |
|
| 17/8 |
Presentation of second quarter 2023 results |
|
| 13/6 |
Presentation at Aktiespararna's Småbolagsdagarna |
|
| 16/5 |
Presentation of first quarter 2023 results with H.C. Andersen Capital |
|
| 20/4 |
Investor Presentation at Økonomisk Ugebrev |
|
| 5/4 |
BioStock | ExpreS2ion Biotechnologies CEO on the rights issue |
|
| 3/4 |
BioStock | Investor Pitch |
|
| 31/3 |
2023 Rights Issue Webinar hosted by HC Andersen Capital |
|
| 30/3 |
Swiss Nordic Bio |
|
| 15/2 |
Presentation of fourth quarter and full-year 2022 results with H.C. Andersen Capital |
|
| 11/2 |
Biotech Showcase |
|
Investor Relations